Taurine for Type 2 Diabetes
Taurine (typically 3 g/day) shows early promise for improving insulin resistance and fasting glucose in type 2 diabetes, but the evidence is preliminary and its effect on HbA1c — the key long-term marker — is inconsistent. It is not a substitute for established diabetes treatment.
Why this grade7-layer evidence engine
Two meta-analyses and several small trials point in a favorable direction. A 2022 meta-analysis (PMID 35769396; 209 patients across 5 trials) found significant reductions in HbA1c (SMD -0.41), fasting blood sugar, and HOMA-IR insulin resistance. The larger 2024 meta-analysis (PMID 38755142; 1,024 patients) confirmed significant fasting-glucose and HOMA improvements, but the HbA1c reduction fell just short of statistical significance (p=0.070). Double-blind trials using 3 g/day mirror this split: PMID 32861603 saw HbA1c drop, while PMID 32472292 and PMID 35870947 found gains in fasting glucose and insulin resistance but no clear HbA1c benefit.
The grade stays at a cautious preliminary level because the signal rests on short-term surrogate markers rather than proven clinical outcomes. Every trial lasted only 8 weeks, samples were small (45-120 people), most were run in Iranian populations, and there are no data on long-term complications. The disagreement between the two meta-analyses on HbA1c — the marker that matters most for diabetes management — is the core uncertainty.
Regulators and major clinics do not endorse taurine for diabetes. The US FDA has reviewed it only for food safety ("FDA has no questions"), the WHO's JECFA found "no safety concern... when used as a flavouring agent," and the EU's EFSA has rejected all taurine health claims. Mayo Clinic and Harvard take no position on it for blood sugar. Taurine can also interact with blood-pressure medications, so anyone managing diabetes should treat it as an unproven add-on and consult a clinician rather than relying on it.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.603
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status